Glycoprotein IIb/IIIa receptor inhibitors in combination with vorapaxar, a platelet thrombin receptor antagonist, among patients with non-ST-segment elevation acute coronary syndromes (from the TRACER trial)
- Jan H. Cornel
- , Pierluigi Tricoci
- , Yuliya Lokhnygina
- , David J. Moliterno
- , Lars Wallentin
- , Paul W. Armstrong
- , Philip E. Aylward
- , Robert M. Clare
- , Edmond Chen
- , Sergio Leonardi
- , Frans Van De Werf
- , Harvey D. White
- , Claes Held
- , John Strony
- , Kenneth W. Mahaffey
- , Robert A. Harrington
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations